- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TN-02-0085734

Sribio Pharmaceuticals Private Limited
About Sribio Pharmaceuticals Private Limited
Data last updated:
Sribio Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 20 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2021PTC142942.
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors Ramachandra Sasikumar and Vaideeswaran Mani Iyer.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 792 16th Street Sastri Nagar Vyasarpadi, Chennai, Tamil Nadu, India – 600039.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.43 Lakh, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.08 Lakh (net margin 2.6%) and EBITDA of ₹1.38 Lakh (EBITDA margin 3.3%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Sribio Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0085734).
Company details
Recognitions & Rankings of Sribio Pharmaceuticals
Contact details
Sribio Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressNo 792 16th Street Sastri Nagar Vyasarpadi, Chennai, Tamil Nadu, India – 600039
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sribio Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Sribio Pharmaceuticals Private Limited, buy the company report.
Financials of Sribio Pharmaceuticals Private Limited
FY 2025 filings availableSribio Pharmaceuticals Private Limited reported revenue of ₹41.43 Lakh (up 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 24% in the latest year. EBITDA fell 41% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.38 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.08 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.3% | ||
| Net Profit Margin | 2.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sribio Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sribio Pharmaceuticals Private Limited
Sribio Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramachandra Sasikumar Also directs: Aurz Lifecare LLP | Director | 20 Apr 2021 | 5 Years 6 Months | Current |
| Vaideeswaran Mani Iyer Also directs: Aurz Lifecare LLP | Director | 20 Apr 2021 | 5 Years 6 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Aug 2024 | 100963522 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sribio Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sribio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sribio Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sribio Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Jayraman Suryanarayanan ceased to be Director on 10 Nov 2021.
Frequently asked questions
Sribio Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in specialty, within the trading industry. It was incorporated on 20 April 2021 (5+ years old) and is registered under CIN U51909TN2021PTC142942.
Sribio Pharmaceuticals has 2 current directors:
- Ramachandra Sasikumar - Director
- Vaideeswaran Mani Iyer - Director
The latest financial statements of Sribio Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Sribio Pharmaceuticals is U51909TN2021PTC142942. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sribio Pharmaceuticals was incorporated on 20 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Jayraman Suryanarayanan ceased to be Director on 10 Nov 2021. Ramachandra Sasikumar was appointed as Director on 20 Apr 2021. Vaideeswaran Mani Iyer was appointed as Director on 20 Apr 2021.
Yes, Sribio Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0085734).
The registered office of Sribio Pharmaceuticals is at No 792 16th Street Sastri Nagar Vyasarpadi, Chennai, Tamil Nadu, India – 600039.
Sribio Pharmaceuticals operates in the trading industry, in the specialty segment.
Sribio Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.

